Release Date: 25/01/10 09:44 Summary: Successful Completion of Dual Listing on TSX Price Sensitive: Yes Download Document 39.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%